A new study that suggests inflammation may lead to the death of brain cells in MS may have identified a drug that could block this process.
A new immunotherapy that re-educates the immune system has shown promising results in two early-stage clinical trials.
Scientists have used 3D printing to create a model that could be used to aid MS drug discovery.
Study reveals important mechanism that allows immune cells to attack myelin in MS
Anti-histamine drug clemastine may boost myelin repair in MS
Researchers uncover a molecule that promotes regeneration of myelin
French MS organisation ARSEP celebrates 26th annual conference